Platelet-derived growth factor (PDGF) B chain induces cell proliferation in vitro and is associated with arterial lesions that cause cardiovascular disease. However, it has been difficult to document the biological response to PDGF B gene expression in arteries in vivo. To determine the biologic effects of this growth factor in vivo, we have introduced an eukaryotic expression vector plasmid encoding recombinant PDGF B by direct gene transfer into porcine iliofemoral arteries using DNA liposome complexes. Invest. 1993Invest. . 91:1822Invest. -1829
vivo, their paracrine and autocrine nature, and the cascade of events that can be induced by experimental manipulations. It is often difficult to determine whether a specific gene product induces intimal hyperplasia directly or indirectly through other gene products synthesized in response to injury. Recently, it has become possible to express recombinant genes in vivo by direct gene transfer utilizing retroviral vectors or DNA liposome complexes (6) (7) (8) (9) . Direct gene transfer permits the delivery of a specific recombinant gene into vascular cells at specific sites in vivo and affords the opportunity to determine the effects of a specific gene product in the arterial wall ( 10). To define the function of PDGF B within arteries, we have directly introduced the recombinant gene in porcine arteries in vivo and have shown that expression of recombinant PDGF B can cause intimal hyperplasia. These data suggest that expression of PDGF B can induce vascular lesions relevant to the pathogenesis of atherosclerosis and restenosis.
Methods
Plasmids and cell transfection. The PDGF B expression vector used for in vitro and in vivo experiments was prepared by ligating the SalIXbal fragment of the v-sis gene into the Xhol-BamH 1 cloning site of the pSVL vector ( 1) (Pharmacia, LKB Biotechnology, Piscataway, NJ). This vector utilizes the SV40 late promoter to regulate expression of the PDGF B gene. Primary porcine endothelial cell cultures were established as previously described ( 12) to test expression ofthe PDGF B vector. The pSVL/PDGF B plasmid expression vector was transfected into porcine endothelial cells using 12 Mg of Lipofectin® (Bethesda Research Laboratories, Gaithersburg, MD) and 5 Mg of DNA (stock concentration > 1 mg/ml) ( 13) . Culture transduced endothelial cells were assayed for secretion ofrecombinant PDGF BB supernatants ( 10%) with a colorimetric proliferation assay ( 14) using NIH 3T3 cells, and a fourfold or greater increase in proliferative activity was observed. No evidence ofcell transformation was observed in endothelial or vascular smooth muscle cells stably transduced with this vector. The E. coli ,B-galactosidase expression vector was prepared by cloning the 3-galactosidase gene into the pDOL vector, which was derived from the Moloney murine leukemia virus (Mo-MuLV) ( 15 ) . The wild type Mo-MuLV LTR provided the promoter for the ,B-galactosidase gene.
Gene transfer in vivo. In vivo arterial gene transfer was performed in 15 pigs, 9 with the recombinant PDGF B gene and 6 with a control reporter gene, E. coli /3-galactosidase. Double balloon catheters were positioned in the iliofemoral arteries as previously described (6) . The arterial segment was rinsed with 5 ml saline and 5 ml Opti-MEM to clear the vessel ofblood. Approximately 10 min before the insertion of the catheter, the DNA liposome conjugates were prepared. 5 Ml lipofectin was diluted into 0.2 ml Opti-MEM at room temperature, and [2] [3] [4] [5] Mug plasmid DNA (stock concentration > 1 mg/ml) was added and mixed by gentle tapping. The solution remained at room temperature for 5-10 min, and 0.5 ml Opti-MEM was added to the DNA liposome solution. The solution was instilled into the arterial space between the two balloons at 150 mmHg, measured by a pressure transducer, and allowed to incubate for 20 min. Following incubation, the catheter was removed and arterial circulation was restored. In all pigs, both the left and right iliac arteries were transfected. At the time of pigs' death, the iliofemoral arteries were fixed in situ under physiological distending pressures (-90 mmHg) with formalin or methyl Carnoy's solution (60% methanol, 30% ethanol, 10% glacial acetic acid by volume percent) for 20 min. 5 pigs were killed at 1 wk and 10 pigs were killed at 3 wk for DNA, mRNA, protein, and histology analysis. A 3-wk time point was selected since recombinant genes have been shown to be stably expressed in vascular cells at 2-3 wks (6, 10) and any intimal thickening induced by arterial manipulation should be observed by this time point ( 16) .
Polymerase chain reaction analysis. Recombinant PDGF gene transfer in arterial segments was analyzed by PCR of genomic DNA using 35 cycles of denaturation (940C, 1 min), annealing (60'C, 2 min), and polymerization (720C, 1 min) as previously described ( 13 
Results
To investigate the biological effects of the recombinant PDGF B gene in vivo, the expression vector plasmid was transfected into porcine iliofemoral arteries. Conditions for direct arterial gene transfer of the recombinant PDGF B gene into porcine iliofemoral arteries were established that minimized vessel injury. In order to determine an instillation pressure ofthe DNA liposome solution that did not injure the vessel wall, double balloon catheters (USCI, Billerica, MA) were positioned in the right and left iliofemoral arteries of two Yorkshire pigs. Phosphate buffered saline was instilled into the central space of the catheter into the left iliofemoral artery at 150 mmHg and into the right iliofemoral artery at 350 mmHg for 30 min. Three weeks later, the vessels were fixed in situ with formalin at physiological distending pressures and analyzed by morphometry. Intimal and medial areas were measured, and intimal to medial area ratios were determined. Intimal hyperplasia was not observed in these iliofemoral arteries following instillation of saline at 150 mmHg, but, in contrast, intimal thickening was present following saline infusion at a higher pressure, 350 mmHg ( Fig. 1 A vs. B) . Measurements of intimal-to medialarea ratios revealed a significant difference between vessels instilled at 150 mmHg and those instilled at 350 mmHg, 0.09±0.01 vs. 0.26±0.04, respectively (P = 0.005). In all subsequent gene transfer experiments, genetic material was instilled at 150 mmHg.
Three weeks following transfection of iliofemoral arteries, the presence of the plasmid encoding the recombinant PDGF B gene was confirmed in transfected arteries using DNA PCR analysis (Fig. 2) . The recombinant PDGF B gene was detected in transfected right and left iliofemoral arterial segments (Fig.  2 , lanes I and 2) but not in nontransfected carotid arterial segments from the same pig (Fig. 2, lane 3 3, lanes 4 vs. 2 ) from the same animal. Expression ofrecombinant PDGF BB protein was analyzed in transduced arterial segments by immunohistochemistry using a monoclonal antibody to human PDGF BB. Control pigs were transfected with a vector expressing f3-galactosidase. No PDGF protein was detected by immunostaining in the intima or media, ofarteries transfected with the E. coli f3-galactosidase expression vector (Fig. 4 A-C) , indicating that the levels of endogenous protein in uninjured arteries transfected with a reporter gene at a low pressure ( 150 mmHg) were below the level ofdetection. In contrast, porcine arteries transfected with the PDGF B gene at a low pressure ( 150 mmHg) demonstrated immunoreactive protein in the intima, media, and adventitia (Fig. 4 D, E, F gene transduced vessels must be recombinant protein, possibly in combination with endogenous protein produced in response to the recombinant PDGF B gene. Recombinant PDGF B gene expression was documented most definitively by the presence of its mRNA (Fig. 3) . We compared expression of recombinant PDGF BB protein with endogenous PDGF protein induced by balloon injury of nontransduced porcine arteries to determine the degree of vessel trauma necessary to detect endogenous PDGF protein. (500 mmHg) demonstrated PDGF immunoreactive protein in the intima and media (Fig. 4 G, H, I ). (Fig. 5 A, B, C) , and were not seen in E. coli f-galactosidase transduced arteries (Fig. 5 D) 7 d after direct gene transfer. In PDGF transfected vessels, the PDGF immunoreactive staining was mostly not associated with macrophages (Fig. 5 F) . These data suggest that macrophages may contribute some PDGF protein, but it is unlikely that the majority ofthe PDGF protein observed in the intima is synthesized by these rare cells. Similar observations were made using a nonspecific esterase stain for the macrophage (data not shown).
To evaluate the response ofthe arterial wall to expression of recombinant PDGF BB protein, the transfected artery segments were examined at 21 d by light microscopy. Arteries transduced with the PDGF B gene demonstrated intimal thickening in contrast to E. coli fl-galactosidase transduced arteries (Fig. 6, A vs. B) . Quantitative morphometry analysis of intimal and medial thickness revealed an eightfold greater intimalto-medial ratio in PDGF B gene transfected arteries compared with E. coli f3-galactosidase transduced vessels, 0.32±0.04 vs. 0.04+0.01, respectively (P = 0.001 ) (Fig. 7) . C.
of the artery (22, 23 ity ofvessel injury and was not detected in vessels transduced at low pressures.
The mechanism by which PDGF is associated with intimal hyperplasia is not clear. Previous studies using [3HI thymidine labeling in rat carotid artery injury models have suggested that the effects of PDGF could not be accounted for by its mitogenic effects alone, raising the possibility that PDGF mediates its effect in part by stimulating migration of medial smooth muscle cells into the intima (4). Infusion of recombinant PDGF BB into rat carotid arteries following injury also increased intimal thickening primarily by migration of smooth muscle cells from the media to the intima (5 
